An in vitro study demonstrated that knocking down ZEB1‐AS1 inhibited cell growth, migration, invasion, and triggered apoptosis in NSCLC and the overexpression of ZEB1‐AS1 was correlated with poor prognosis in NSCLC patients.7 Here, ZEB1 is linked to non-small cell lung carcinoma.